CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,802 | +242.3% | 64,306 | +151.4% | 0.00% | – |
| Q2 2023 | $280,090 | -81.4% | 25,579 | -85.2% | 0.00% | -100.0% |
| Q1 2023 | $1,506,066 | +45999.4% | 172,714 | +33050.5% | 0.00% | – |
| Q4 2022 | $3,267 | -18.3% | 521 | +52000.0% | 0.00% | – |
| Q3 2022 | $4,000 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2022 | $29,462,000 | -5.2% | 9,987 | -0.1% | 0.00% | – |
| Q1 2022 | $31,088,000 | -92.6% | 9,996 | -92.0% | 0.00% | -100.0% |
| Q4 2021 | $421,821,000 | +732.4% | 124,799 | +798.9% | 0.00% | – |
| Q3 2021 | $50,677,000 | +67.3% | 13,884 | +99.9% | 0.00% | – |
| Q2 2021 | $30,285,000 | -76.9% | 6,946 | -75.9% | 0.00% | – |
| Q1 2021 | $130,866,000 | +77.1% | 28,825 | +123.8% | 0.00% | – |
| Q4 2020 | $73,914,000 | -51.1% | 12,877 | -38.3% | 0.00% | – |
| Q3 2020 | $151,070,000 | +475.2% | 20,866 | +177.3% | 0.00% | – |
| Q2 2020 | $26,266,000 | -29.0% | 7,526 | -69.9% | 0.00% | – |
| Q1 2020 | $37,018,000 | +138.1% | 25,012 | +215.3% | 0.00% | – |
| Q4 2019 | $15,549,000 | -69.4% | 7,933 | -20.1% | 0.00% | – |
| Q3 2019 | $50,857,000 | +6.2% | 9,933 | +48.5% | 0.00% | – |
| Q2 2019 | $47,879,000 | -71.0% | 6,687 | -46.2% | 0.00% | – |
| Q1 2019 | $165,124,000 | +673.4% | 12,434 | +545.3% | 0.00% | – |
| Q3 2018 | $21,351,000 | -17.4% | 1,927 | 0.0% | 0.00% | – |
| Q2 2018 | $25,860,000 | -75.8% | 1,927 | -96.5% | 0.00% | – |
| Q3 2015 | $106,700,000 | -11.9% | 55,000 | +22.2% | 0.00% | – |
| Q2 2015 | $121,050,000 | -12.5% | 45,000 | +125.0% | 0.00% | – |
| Q1 2015 | $138,400,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |